Delivery Order SPE2DB22D1106-SPE2DB25FEQV5
Award Date 5/30/25
Potential Completion Date 6/2/25
Potential Value $9.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse 60 mg capsules (100-count units) under a firm fixed-price contract valued at $9,359.80, with an ultimate completion date of September 11, 2025. This non-set-aside, competitively awarded delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Vyvanse 30 mg capsules (100-count units) with a ceiling value of $4,698.42. This non-competitive delivery order represents a firm fixed price transaction with a completion date of September 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on September 8, 2025, for the supply of Vyvanse 30 mg capsules (100 count) with a ceiling value of $2,904.62. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Vyvanse 30 mg capsules (quantity: 100s) valued at $6,670.67 with a completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government,...
- The Defense Logistics Agency awarded a $3,076.43 delivery order to AmerisourceBergen Drug Corp for Vyvanse 40 mg capsules (100-count) on June 24, 2025, with an ultimate completion date of June 25, 2025. This firm fixed-price, non-set-aside contract represents a small-value pharmaceutical delivery supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse 30 mg capsules (100-count units) valued at $1,878.48 under a firm fixed-price contract type. The delivery order was competitively awarded without a set-aside designation and is scheduled for completion by September 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vyvanse 30 mg capsules (100-count units) valued at $2,901.09 under a firm fixed-price contract type. The order was competitively awarded without a set-aside designation and is scheduled for completion by November 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Vyvanse 30 mg capsules (100-count units) valued at $12,128.78 under firm fixed-price terms. This non-set-aside, competitively awarded delivery order represents a continuation of pharmaceutical procurement through the federal medical supply chain, with performance based in Conshohocken, Pennsylvania, and completion scheduled for September 25, 2025. AmerisourceBergen Drug...
- The Defense Department's Medical Supply Chain, through the Defense Logistics Agency (DLA), awarded a delivery order valued at $35,751.84 to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules 60mg. The contract was awarded on October 16, 2025, with an ultimate completion date of October 17, 2025, under firm fixed-price terms with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a $1,413.54 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Vyvanse 30 mg capsules (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 5, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...